Immune Reconstitution and Immunotherapy After Autologous Hematopoietic Stem Cell Transplantation
Autor: | Daniel B. Rubinstein, Michel Symann, Thierry Guillaume |
---|---|
Rok vydání: | 1998 |
Předmět: |
Cellular immunity
T-Lymphocytes medicine.medical_treatment Immunology Hematopoietic stem cell transplantation Transplantation Autologous Biochemistry Immune system Neoplasms medicine Animals Humans Growth Substances B-Lymphocytes Chemotherapy business.industry Hematopoietic Stem Cell Transplantation Immunity Hematopoietic stem cell Immunotherapy Cell Biology Hematology Hematopoietic Stem Cells Transplantation medicine.anatomical_structure Cytokines Stem cell business |
Zdroj: | Blood. 92:1471-1490 |
ISSN: | 1528-0020 0006-4971 |
DOI: | 10.1182/blood.v92.5.1471.417k39_1471_1490 |
Popis: | APPROXIMATELY 10,000 autologous hematopoietic stem cell (HSC) transplants are performed worldwide each year for malignant diseases.[1][1] Results of randomized trials in recent years suggest that high-dose chemotherapy followed by infusion of autologous HSCs can offer prolonged disease-free survival |
Databáze: | OpenAIRE |
Externí odkaz: |